OCMSNCT07508917
Effects of 5-Methyltetrahydrofolic Acid Supplementation on Maternal Health and One-Carbon Metabolism During Lactation
At risk: Primary completion moved 31 days later.
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗
Notable Recruitment opened Show 5 more changesShow less
- Eligibility criteria expanded, about 8 words
- Primary completion pushed from Nov 30, 2026 to Dec 31, 2026
- Study completion pushed from Feb 28, 2027 to Apr 30, 2027
- Secondary endpoints: details revised at 1 of 16 entries
- Site details revised at 2 of 2 sites
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Incidence of Adverse Events
Timeframe: Baseline, 6 weeks, 4 months
Change in breast milk 5-MTHF concentration
Timeframe: Baseline, 6 weeks
Secondary (16)
Change in plasma 5-MTHF concentration
Change in breast milk one-carbon metabolite concentration
Change in plasma one-carbon metabolite concentration
Change in Human Milk Oligosaccharide (HMO) concentration
Change in Maternal Plasma Glucose Concentration
Show 11 moreShow less
Change in Maternal Plasma Glycated Hemoglobin (HbA1c) Concentration
Change in Maternal Plasma Insulin Concentration
Change in Maternal Plasma Triglyceride (TAG) Concentration
Change in Maternal Blood Total Cholesterol Concentration
Change in Maternal Blood LDL Cholesterol Concentration
Change in Maternal Blood HDL Cholesterol Concentration
Change in Maternal Blood Alanine Aminotransferase (ALT) Levels
Change in Maternal Blood Aspartate Aminotransferase (AST) Levels
Change in Maternal Blood Gamma-Glutamyl Transferase (GGT) Levels
Change in Symptom Checklist-90-Revised (SCL-90-R) scale
Change in infant BMI z-score
Arms and interventions
5-MTHF SupplementationExperimental
Dietary Supplement (5-MTHF)
PlaceboPlacebo comparator
Placebo
Dietary supplements: 5-MTHF Supplementation
Other: Placebo
Sites
2 sites in 1 country